{"schema_version":"alpha-profile-public-v1","slug":"christopher-j-senner-2","canonical_url":"https://registry.alpha.ac/people/christopher-j-senner-2","as_of":"2026-09-22T03:38:06.358045+00:00","published_at":"2026-09-02T02:37:22.285759+00:00","last_reviewed_at":"2026-05-16T02:04:19.627+00:00","identity":{"display_name":"Christopher J. Senner","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Quince Therapeutics, Inc.","company_slug":"quince-therapeutics-inc","exchange":"NASDAQ","ticker":"QNCX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2019-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","effective_date":"2025-04-23","last_checked_at":"2026-04-28T23:51:01.281+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=christopher-j-senner-2","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=christopher-j-senner-2&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Christopher Senner is an experienced biotechnology executive with extensive financial expertise. He has served as Executive Vice President and Chief Financial Officer of Exelixis, Inc. since 2015 and previously held senior financial roles at Gilead Sciences and Wyeth, including CFO of Wyeth's U.S. pharmaceuticals business."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Quince Therapeutics, Inc.","organizationId":"quince-therapeutics-inc","title":"Director","period":"2019-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Quince Therapeutics, Inc.","company_slug":"quince-therapeutics-inc","exchange":"NASDAQ","ticker":"QNCX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2019-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","effective_date":"2025-04-23","last_checked_at":"2026-04-28T23:51:01.281+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Christopher J. Senner as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:19.825797+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNCX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","published_at":"2025-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:19.688435+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Christopher J. Senner currently serves as Director at Quince Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-23","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:19.786529+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNCX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","published_at":"2025-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:19.688435+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Christopher J. Senner serves on Audit.","claim_state":"verified","valid_from":"2025-04-23","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:19.809444+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNCX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","published_at":"2025-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:19.688435+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Exelixis, Inc.","claim_text":"Christopher J. Senner is linked to Exelixis, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:19.926981+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNCX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","published_at":"2025-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:19.688435+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Executive Vice President and Chief Financial Officer","claim_text":"Christopher J. Senner is also listed as Executive Vice President and Chief Financial Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:19.906928+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNCX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","published_at":"2025-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:19.688435+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Christopher J. Senner as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:19.861037+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNCX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","published_at":"2025-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:19.688435+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Christopher J. Senner as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:19.844472+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNCX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","published_at":"2025-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:19.688435+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:christopher-j-senner-2","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2019-01-01 · current","organization":"Quince Therapeutics, Inc.","organization_id":"quince-therapeutics-inc"},"claim_text":"Director at Quince Therapeutics, Inc. (2019-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/christopher-j-senner-2#profile","url":"https://registry.alpha.ac/people/christopher-j-senner-2","dateModified":"2026-05-16T02:04:19.627+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/christopher-j-senner-2#person","name":"Christopher J. Senner","url":"https://registry.alpha.ac/people/christopher-j-senner-2","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Quince Therapeutics, Inc.","tickerSymbol":"NASDAQ: QNCX"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","memberOf":{"@type":"Organization","name":"Quince Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/quince-therapeutics-inc","tickerSymbol":"NASDAQ: QNCX"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","name":"QNCX DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/christopher-j-senner-2"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T02:04:19.627+00:00","observed_at":"2026-09-22T03:38:06.358045+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"christopher-j-senner-2","canonical_url":"https://registry.alpha.ac/people/christopher-j-senner-2"},"publication":{"published_at":"2026-09-02T02:37:22.285759+00:00","last_reviewed_at":"2026-05-16T02:04:19.627+00:00","as_of":"2026-09-22T03:38:06.358045+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/christopher-j-senner-2","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/christopher-j-senner-2","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/christopher-j-senner-2.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}